All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

The Aurora EV-ICD MRI SureScan is similar in size and shape to traditional ICDs, but it is implanted outside of the patient’s heart and veins.

The study included ECG data from more than 900,000 U.S. veterans.

Akhil Narang, MD, explained that the two technologies can be used together to deliver high-quality patient care. 

According to Shockwave, the updated IVL catheter can deliver 50% more pulses than its previous offering. 

The self-expanding valve, already approved by the FDA, was designed with three gold markers to boost implanter efficiency, an updated catheter tip and a more flexible delivery system.

Dihydropyridines such as amlodipine have been the topic of some debate in recent months due to fears they lead to significant side effects. 

This past summer McKinsey Global Institute projected almost one-third of workplace activities in the U.S. will be automated by 2030, driving something like 12 million “occupational transitions.” 

The nearly half-billion-dollar loan balance will convert to shares of common stock, held by lender Stonepeak, with Akumin transitioning to a privately held company.